Related Experiment Video

Updated: Aug 24, 2026

Intracellular Refolding Assay
07:18

Intracellular Refolding Assay

Published on: January 24, 2012

Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification

Hiroshi Sakamoto1, Tetsuo Mashima, Kazuo Yamamoto

  • 1Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, 170-8455, Japan.

Insights

Methylglyoxal (MG) modifies heat-shock protein 27 (Hsp27), impacting cell survival. This discovery reveals MG as a key regulator of apoptosis and cellular response to anti-tumor drugs.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Methylglyoxal (MG) is a reactive byproduct of glycolysis.
  • MG can modify proteins under physiological conditions.
  • Heat-shock proteins (Hsps) play crucial roles in cellular stress response.

Purpose of the Study:

  • To identify major MG-modified proteins in cells.
  • To elucidate the functional consequences of MG modification on Hsp27.
  • To investigate the role of MG-modified Hsp27 in apoptosis and drug sensitivity.

Main Methods:

  • Proteomic analysis to identify MG-modified proteins.
  • Site-directed mutagenesis to investigate specific residue modification.
  • Caspase activation assays to assess apoptosis.
  • Cell viability assays to determine drug sensitivity.

Main Results:

  • Heat-shock protein 27 (Hsp27) was identified as a major MG-modified protein.
  • MG modification occurs specifically at Arg-188, forming argpyrimidine.
  • This modification is critical for Hsp27's ability to inhibit caspase activation.
  • Inhibiting MG modification of Hsp27 sensitizes cells to anti-tumor drug-induced apoptosis.

Conclusions:

  • Methylglyoxal (MG) directly modifies Hsp27 at Arg-188, forming argpyrimidine.
  • MG modification of Hsp27 is essential for its role in regulating apoptosis.
  • MG acts as a novel modulator of cell survival by altering protein function.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...